Captor Therapeutics Spolka Akcyjna (CTX.WA)
PLN 32.2
(1.58%)
PLN 32.2
(1.58%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -15.19 PLN | -89.4% |
| 2022 | -8.02 PLN | -0.38% |
| 2021 | -7.99 PLN | -98.76% |
| 2020 | -4.02 PLN | -50.0% |
| 2019 | -2.68 PLN | -97.06% |
| 2018 | -1.36 PLN | -2359.31% |
| 2017 | -0.06 PLN | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -2.04 PLN | 17.41% |
| 2024 Q2 | -2.14 PLN | -4.9% |
| 2023 Q4 | -2.47 PLN | 33.6% |
| 2023 Q1 | -3.09 PLN | -166.38% |
| 2023 Q3 | -3.72 PLN | 46.16% |
| 2023 FY | - PLN | -89.4% |
| 2023 Q2 | -6.91 PLN | -123.62% |
| 2022 Q2 | -2.36 PLN | 12.27% |
| 2022 FY | - PLN | -0.38% |
| 2022 Q4 | -1.16 PLN | 37.63% |
| 2022 Q3 | -1.86 PLN | 21.19% |
| 2022 Q1 | -2.69 PLN | -1.89% |
| 2021 Q2 | -1.81 PLN | -10.37% |
| 2021 Q4 | -2.64 PLN | -22.79% |
| 2021 Q3 | -2.15 PLN | -18.78% |
| 2021 FY | - PLN | -98.76% |
| 2021 Q1 | -1.64 PLN | -234.69% |
| 2020 FY | - PLN | -50.0% |
| 2020 Q3 | -1.94 PLN | 0.0% |
| 2020 Q4 | -0.49 PLN | 74.74% |
| 2019 FY | - PLN | -97.06% |
| 2018 FY | - PLN | -2359.31% |
| 2017 FY | - PLN | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Bioceltix S.A. | -3.49 PLN | -335.244% |
| BIOTON S.A. | 0.03 PLN | 57420.755% |
| Mabion S.A. | 2.55 PLN | 695.686% |
| Molecure S.A. | -1.09 PLN | -1293.578% |
| NanoGroup S.A. | -0.39 PLN | -3794.872% |
| Pharmena S.A. | 2.60 PLN | 684.231% |
| Poltreg S.A. | -2.91 PLN | -421.993% |
| Pure Biologics Spólka Akcyjna | -11.19 PLN | -35.746% |
| Ryvu Therapeutics S.A. | -4.02 PLN | -277.861% |
| Synthaverse S.A. | 0.07 PLN | 22537.223% |
| Urteste S.A. | -4.32 PLN | -251.62% |